August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on the role of 18F-FDG positron emission tomography/computed tomography (PET/CT) in cardiac sarcoid detection and therapy monitoring.
The recognition that randomized prospective trials are not available for this rare disease and are unlikely to be conducted has prompted the Cardiovascular Council of the SNMMI and the ASNC to assemble a multidisciplinary team of experts not only in imaging but also in clinical cardiology, cardiac electrophysiology, heart failure, and systemic sarcoidosis to develop this comprehensive consensus statement.
The full document can be read here.
For more information: www.asnc.org, www.snmmi.org